WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Laza Medical raises up to $160M in a Series B led by GE HealthCare Evident Vascular clears its IVUS guidance system for peripheral procedures GE HealthCare clears aortic stenosis and lung scanning software for Vscan Air FDA draws more than 500 comments on its generative AI device framework Neurotronics clears a sleep time algorithm that reads a pulse oximeter signal BRIJ Medical upsizes a $3M raise to $5M for its incision management line Globus Medical bought Synaptive Medical out of receivership in August Lincoln Ventures agrees to buy Aegis Medical in an all-stock reverse takeover FDA adds kidney disease and diabetes data to the Symplicity Spyral label Laza Medical raises up to $160M in a Series B led by GE HealthCare Evident Vascular clears its IVUS guidance system for peripheral procedures GE HealthCare clears aortic stenosis and lung scanning software for Vscan Air FDA draws more than 500 comments on its generative AI device framework Neurotronics clears a sleep time algorithm that reads a pulse oximeter signal BRIJ Medical upsizes a $3M raise to $5M for its incision management line Globus Medical bought Synaptive Medical out of receivership in August Lincoln Ventures agrees to buy Aegis Medical in an all-stock reverse takeover FDA adds kidney disease and diabetes data to the Symplicity Spyral label

Seed

ArrayPatch raises 3.2 million euros for a microneedle patch made of the drug itself

MedDevice Startups Staff · 1 day ago · 2 min read · Via ArrayPatch release (GlobeNewswire)

ArrayPatch said on November 5 that it closed a second tranche of 1.6 million euros, taking its oversubscribed seed round to 3.2 million euros. Lakeside Capital led again, with impact investor WakeUp Capital as co-lead. Spark Venture Funding, DeepIE Ventures, Enterprise Ireland, the Boole Investment Syndicate and private investors joined. Andrew Parish of WakeUp Capital takes a board seat alongside Neil Thomas, the recently appointed chair.

The University College Cork spinout builds DerMap, a dissolving microneedle patch. Its needles are formed entirely from the drug being delivered, with no polymer carrier, which lifts the dose a patch can hold. The lead program, GLP-DerMap, is a preclinical patch alternative to GLP-1 injections for obesity and diabetes. Two further programs target basal cell carcinoma and onychomycosis. The money funds work toward first-in-human studies.

Questions & Answers

How much has ArrayPatch raised in its seed round?

ArrayPatch closed a second tranche of 1.6 million euros on November 5, 2026, bringing its oversubscribed seed round to 3.2 million euros. Lakeside Capital led the round, with WakeUp Capital as co-lead.

What is ArrayPatch's DerMap microneedle patch?

DerMap is ArrayPatch's dissolving microneedle platform. The needles are formed entirely from the drug being delivered, with no polymer carrier, which allows higher drug loading. The lead program, GLP-DerMap, is a preclinical patch alternative to GLP-1 injections.

Where is ArrayPatch based?

ArrayPatch is based in Cork, Ireland, and was spun out of University College Cork. Waleed Faisal is founder and chief executive.

← Back to Fundraising